A Point Mutation in the Mitochondrial Cytochrome b Gene Obviates the Requirement for the Nuclear Encoded Core Protein 2 Subunit in the Cytochrome bc1 Complex in Saccharomyces cerevisiae*

(Received for publication, August 7, 1996, and in revised form, November 4, 1996)

Jean-Paul di Rago Dagger , Frédéric Sohm §, Claire Boccia , Geneviève Dujardin , Bernard L. Trumpower and Piotr P. Slonimski

From the Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique, Laboratoire propre associé à l'Université Pierre et Marie Curie, Gif-sur-Yvette, F-91190 France and the  Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

A yeast mutant (cor2-45) in which approximately half of the C terminus of core protein 2 of the cytochrome bc1 complex is lacking due to a frameshift mutation that introduces a stop at codon 197 in the COR2 gene fails to assemble the cytochrome bc1 complex and does not grow on non-fermentable carbon sources that require respiration. The loss of respiration is more severe with this frameshift mutation than with the complete deletion of the COR2 gene, suggesting deleterious effects of the truncated core 2 protein. A search for extragenic suppressors of the nuclear cor2-45 mutation resulted (in addition to the expected nuclear suppressors) in the isolation of a suppressor mutation in the mitochondrial DNA that replaces serine 223 by proline in cytochrome b.

Assembly of the cytochrome bc1 complex and the respiratory deficient phenotype of the cor2-45 mutant are restored by the proline for serine replacement in cytochrome b. Surprisingly, this amino acid replacement in cytochrome b corrects not only the phenotype resulting from the cor2-45 frameshift mutation, but it also obviates the need for core protein 2 in the cytochrome bc1 complex since it alleviates the respiratory deficiency resulting from the complete deletion of the COR2 gene. This is the first report of a homoplasmic missense point mutation of the mitochondrial DNA acting as a functional suppressor of a mutation located in a nuclear gene and the first demonstration that the supernumerary core protein 2 subunit is not essential for the electron transfer and energy transducing functions of the mitochondrial cytochrome bc1 complex.


INTRODUCTION

In the mitochondrial respiratory chain, the cytochrome bc1 complex transfers electrons from ubiquinol to cytochrome c and couples this electron transfer to vectorial proton translocation across the inner mitochondrial membrane (for reviews, see Refs. 1, 2). The structure of this respiratory enzyme is best characterized for yeast, beef, and potato where it consists of 10 or 11 different polypeptide subunits, three of which (cytochrome b, cytochrome c1, and the Rieske iron-sulfur protein) carry redox prosthetic groups, and 7 to 8 polypeptides, which lack redox prosthetic groups (core proteins 1 and 2 and five to six small proteins with molecular masses below 15 kDa). The cytochrome b subunit is encoded by the mitochondrial DNA while all the other subunits of the complex are encoded in the nucleus.

The three subunits carrying redox prosthetic groups have been studied extensively, and their roles in electron transfer and proton translocation have been elucidated. Much less is known about the subunits that do not carry redox prosthetic groups. These are often referred to as supernumerary subunits because they have no counterparts in bacteria such as Paracoccus denitrificans and Rhodospirillum rubrum, where the cytochrome bc1 complex contains only cytochrome b, cytochrome c1, and the Rieske iron-sulfur protein (3, 4). The bacterial and mitochondrial cytochrome bc1 complexes exhibit essentially identical electron transfer and proton translocating activities, suggesting that the supernumerary polypeptides of the mitochondrial enzyme are not directly involved in the energy transducing mechanism (5).

This view has received support with the discovery that the core proteins of the Neurospora crassa and plant cytochrome bc1 complexes are MPPs,1 the proteases that process the presequences of a number of nuclear encoded precursors of mitochondrial proteins (6-10; see Refs. 11-13 for reviews). In yeast alpha -MPP and beta -MPP are water-soluble proteins located in the matrix and not membrane bound (14-16). Although they are proteolytically inactive, the two core proteins of the yeast cytochrome bc1 complex show structural similarities to MPP (17, 18). Thus, it is believed that the core proteins and MPP have a common phylogenetic origin in an ancestral protease and that the proteolytic activity became detached from the yeast complex after some gene duplication occurred (6, 12).

The question which remains to be addressed is what are the functions of the proteolytically inactive core proteins of the yeast cytochrome bc1 complex? Yeast mutants with a structural deficiency in either core protein 1 or core protein 2 fail to properly assemble the cytochrome bc1 complex and, consequently, they do not grow or have extremely reduced growth rates on non-fermentable substrates (17, 18). Here we aimed to know if the respiratory capacity can be restored in such a mutant by a second mutation in another gene, thus allowing the assembly of bc1 complex despite a core protein deficiency.

We first describe a mutant in which about half of core protein 2 is lacking due to a frameshift mutation in its gene and show that the assembly of the bc1 complex is blocked in this mutant. We then show that the assembly and activity of the complex are restored by a second mutation located in the mitochondrial DNA which replaces serine 223 by proline in cytochrome b and that this single missense mutation eliminates the need for core protein 2. This is the first report of a homoplasmic missense point mutation of the mitochondrial DNA acting as a functional suppressor of a mutation located in a nuclear gene. This also unequivocally establishes that core protein 2 is not centrally involved in the electron transfer and energy transducing functions of the bc1 complex and emphasizes the question of its biological role.


EXPERIMENTAL PROCEDURES

Strains and Standard Genetics Methods

The genotypes and origins of the strains used in this study are listed in Table I. Procedures for MnCl2 mutagenesis (19), random sporulation and synchronous crosses (20), cytoduction (21), and induction of rho0/rho- cells (22) were described previously.

Table I.

Yeast strains used in this study

CCW30 is a mitochondrial cytoductant of CCB2 into CW30. CW30/SM45 is derived from CW30. CCB2 is a mitochondrial cytoductant of SM45/CB2 into JC8/55. CB10-2a was obtained by random sporulation of diploids issued from the cross between CW30/SM45 and KL14-4A/60. CHR2::40k0 is a mitochondrial cytoductant of CCB2 into HR2::40k0. The strains CW30, CCW30, CW30/SM45, SM45/CB2, CCB2, and CHR2::40k0 contain the mitochondrial genome devoid of all introns (46).
Strain Nuclear genotype Mitochondrial genotype Source

CW30  alpha ade2, leu2, trp1, his3, ura3 [rho+] M. Labouesse
CCW30  alpha ade2, leu2, trp1, his3, ura3 [rho+ cobS223P] This work
CW30/SM45  alpha ade2, leu2, trp1, his3, ura3, cor2-45 [rho+] This work
SM45/CB2  alpha ade2, leu2, trp1, his3, ura3, cor2-45 [rho+ cobS223P] This work
CCB2 a leu1, kar1 [rho+ cobS223P] This work
CB10-2a a his-, cor2-45 [rho+] This work
W303-1A a ade2, leu2, trp1, his3, ura3 [rho+] R. Rothstein
HR2::40k0  alpha leu2, trp1, his4, cor2::LEU2 [rho+] Ref. 17
CHR2::40k0  alpha leu2, trp1, his4, cor2::LEU2 [rho+ cobS223P] This work
JC8/55 a leu1, kar1, canr [rho0] Ref. 40
KL14-4A/60 a trp2, his1 [rho0] Ref. 41
CK290 a leu1, kar1, canr [rho+ cob-M7622] Ref. 42
CK225 a leu1, kar1, canr [rho+ cob-M4410] Ref. 43
CKV45 a leu1, kar1, canr [rho+ oxi1-V45] Ref. 44
CKG481 a leu1, kar1, canr [rho+ oxi3-G481] Ref. 45

Isolation and Sequence Determination of the Mutant CW30/SM45

The mutant SM45 was selected as a respiratory deficient mutant after MnCl2 mutagenesis of the wild-type strain CW30 and shown by crosses to be a nuclear mutation (see "Results"). Genomic DNAs were prepared from the mutant and wild-type strains (23) and were PCR amplified with two primers flanking the COR2 gene: C1, 5'-GCTCGAACGATTAGGACGGG and C2, 5'-CCTTTAGTTTTTCGTTTTGTAC (the 5'-ends are located, respectively, at nucleotide positions -58 and +1141 from the first base of the initiator AUG codon; see Ref. 18). PCR was performed from 100 ng of genomic DNA with 25 pmol of each primer in 50 µl of each 200 µM dNTP, 50 mM KCl, 10 mM Tris/HCl, pH 8.8, 1.5 mM MgCl2, and 0.1% Triton X-100, containing 2.5 units of Taq polymerase (Bioprobe), at 95 °C for 3 min, 55 °C for 30 s, and 72 °C for 1.5 min (for 1 cycle), at 95 °C for 30 s, 55 °C for 45 s, and 72 °C for 1.5 min (for 28 cycles), and at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 15 min (for 1 cycle). The PCR products were sequenced twice from separately made PCR products using a primer extension procedure developed by E. Coissac2 with primers C1 and C2 and three primers located between C1 and C2: S1, 5'-GCTTTGAAATTAGTCAGAG (+189); S2, 5'-CCGAAGACCAATTGTATGCC (+424); and S3, 5'-GGTGAAGAAAACAGGG (+675).

Isolation and Genetic Analysis of Revertants Issued from the Mutant CW30/SM45

Twenty-two independent subclones of the mutant SM45 were grown until stationary phase in 10% glucose, 1% yeast extract, 1% bactopeptone, and 20 mg/liter adenine. About 5 × 108 cells of each culture were plated on 2% glycerol, 1% yeast extract, 1% bactopeptone, and 2% agar. Eleven subclones gave at least one colony after 1 week of incubation at 28 °C. Twenty-two isolates (2 per original subclone) corresponding to at least 11 independent reversion events were retained for further analysis. The revertants were treated with ethidium bromide to eliminate their mitochondrial DNA (rho0) and then back-crossed to the original mutant (strain CB10-2a). With one revertant, called SM45/CB2, all the resulting diploid cells were respiratory deficient, indicating that this revertant was either nuclear recessive or mitochondrial.

The 21 other revertants gave respiratory competent diploids and were thus nuclear dominant. These were not further analyzed. Two additional test-crosses proved that the revertant SM45/CB2 was the result of a mutation located in the mtDNA. First, the original mutant (strain CB10-2a) was treated with ethidium bromide to eliminate its mitochondrial DNA (rho0) and then crossed to the revertant SM45/CB2; the resulting diploid progeny was composed entirely (barring the spontaneous rho- cells occurring in all yeast cultures) by respiratory competent cells (it would have been composed of only respiratory deficient cells if the suppressor was nuclear recessive). Second, the revertant SM45/CB2 was crossed synchronously to the original mutant (strain CB10-2a) and after segregation of mitochondrial heteroplasmons, about 50% of the resulting diploid cells were respiratory competent (mitotic segregation of respiratory competence would not have been observed if the suppressor was nuclear recessive).

The suppressor was localized on mtDNA using a previously described procedure (24). To this end the revertant SM45/CB2 was treated 15 h at 28 °C in 0.4% NaCl containing 10 mg/liter ethidium bromide, and the resulting rho- cells were tested for the retention or loss of the suppressor mutation by crossing with the original mutant (strain CB10-2a). Forty rho- clones having retained the suppressor mutation were then analyzed for the retention or loss of the wild-type alleles of four different mit- mutations previously located on mtDNA (25, 26). As summarized in Table II, the rho- tested were all able to rescue mit- mutations located in the cytochrome b gene, whereas only a minor fraction of them were able to rescue mit- mutations located in the genes COXI and COXII, indicating that the suppressor mutation is located in the cytochrome b gene.

Table II.

Location of the SM45/CB2 suppressor mutation in the cytochrome b gene by rho- deletion mapping

The revertant strain SM45/CB2 was derived from the nuclear respiratory deficient mutant SM45 and shown to carry a suppressor mutation located in mtDNA. In order to localize the suppressor on mtDNA, rho- clones were derived by mild ethidium bromide treatment of the revertant strain and were tested for the retention or loss of the suppressor mutation by crossing to the original mutant. Forty rho- clones that retained the suppressor mutation were crossed pairwise with four mit- mutants previously located in mtDNA: cob-M7622 and cob-M4410 in the cytb gene, oxi1-V45 in the coxII gene, and oxi3-G481 in the coxI gene. +/- denotes the presence/absence of wild-type respiratory competent recombinants in the diploid progeny as indicated by growth on glycerol medium after two days at 28 °C. All the rho- tested rescued the cytb mutants, whereas only a minor fraction of them rescued the coxII and coxI mutants, showing that the suppressor is in cytb. The cob-M7622 mutation is at codon 33 of cytb (G33D, Ref. 42); cob-M4410 is at codon 221 (M221K, Ref. 43).
coxII cytb
coxI n0 of rho-
oxi1-V45 cob-M7622 cob-M4410 oxi3-G481

+ + +  - 1
 - + +  - 31
 - + + + 8

Spectral Analysis of Cytochromes

Optical spectra of cytochromes were recorded at liquid nitrogen temperature with a Cary 128 spectrophotometer after reduction of the cytochromes by dithionite of whole cells grown for 1 day at 28 °C on 2% glucose, 1% yeast extract, 1% bactopeptone, and 2% agar (27).

Sequence Determination of the SM45/CB2 Revertant

The cytochrome b mRNA was sequenced by primer extension with avian myeloblastosis virus reverse transcriptase (Amersham Corp.) from total mitochondrial RNA of the SM45/CB2 revertant (28).

Enzyme Assays and Western Analysis

Mitochondrial membranes were isolated using a procedure described previously (29). Yeast were grown overnight on 2% glucose, 1% yeast extract, 1% bactopeptone, and 2% agar. The cells were harvested by centrifugation at 4,000 × g for 10 min. They were then washed once with distilled water and resuspended in 400 mM mannitol, 50 mM Tris, pH 7.6, and 2 mM EDTA. The yeast were disrupted using glass beads in five 1-min intervals using a Biospec Products Bead-Beater. The cell extract was diluted with 1 volume of ice-cold Tris/mannitol buffer and centrifuged for 10 min at 1,000 × g at 4 °C to remove intact cells. The supernatant was saved and recentrifuged at 1,000 × g for 10 min. Mitochondrial membranes were collected by centrifugation of the supernatant at 16,000 × g for 20 min. Membranes were washed twice with 150 mM NaCl and recentrifuged. Final membrane pellets were resuspended in 50 mM Tris, 1 mM MgSO4, pH 7.6, containing 50% glycerol and stored at -20 °C. Protein concentrations were determined by the method of Lowry et al. (50) as modified by Markwell et al. (51).

Ubiquinol-cytochrome c oxidoreductase activity was assayed at pH 7.0 and 23 °C using the substrate analog 2,3-dimethoxy-5-methyl-6-n-nonyl-1,4-benzoquinol (52). The nonenzymatic rate of cytochrome c reduction was determined by the addition of quinol to the assay buffer and allowing the reaction to proceed for approximately 5 s. The enzymatic rate was then initiated by adding the membrane fraction to the assay buffer. Rates were obtained in duplicate and varied less than 10%. The amounts of proteins used in the enzyme assays are given in the legend of Fig. 2.


Fig. 2. Cytochrome spectra and activities of ubiquinol-cytochrome c reductase. The tracings on the left are optical spectra of the cytochromes recorded from whole cells at liquid nitrogen temperature after reduction by dithionite. Arrows indicate the positions of the alpha  band absorption maxima of cytochrome c (c), cytochrome c1 (c1), cytochrome b (b), and cytochromes aa3 (aa3). The tracings on the right depict the ubiquinol-cytochrome c oxidoreductase activity assayed at pH 7.0 and 23 °C using the substrate analog 2,3-dimethoxy-5-methyl-6-n-nonyl-1,4-benzoquinol (absorbance increase at 550 nm as reduced cytochrome c accumulates versus time). The nonenzymatic rate of cytochrome c reduction was determined by adding quinol (S) to the assay buffer and allowing the reaction to proceed for approximately 5 s. The enzyme reaction was then initiated by adding mitochondria (M). The names of the strains from top to bottom are CW30, wild type (COR2 and cyt.b-S223); CW30/SM45, original cor2-45 frameshift mutation alone (cor2-45 and cyt.b-S223); SM45/CB2, mitochondrial revertant (cor2-45 and cyt.b-P223); HR2::40k0, cor2 deletion alone (cor2::LEU2 and cyt.b-S223); and CHR2::40k0, cor2 deletion with mitochondrial mutation (cor2::LEU2 and cyt.b-P223). The amounts of proteins used in the enzyme assays were: 133 µg (CW30), 176 µg (CW30/SM45), 141 µg (SM45/CB2), 156 µg (HR2::40K0), and 174 µg (CHR2::40K0). The cytochrome c reductase activities/mg of protein expressed relative to that of the wild type strain CW30 were <1% for CW30/SM45, 60% for SM45/CB2, 11% for HR2::40K0, and 42% for CHR2::40K0.
[View Larger Version of this Image (15K GIF file)]


Immunoblot analysis on the mitochondrial membranes prepared as described above was performed with polyclonal antibodies raised against purified cytochrome bc1 complex as described previously (29). The amounts of protein used in the immunoblot analysis are given in the legends of Fig. 4.


Fig. 4. Immunoblot analysis of the core 1 and core 2 proteins of the cytochrome bc1 complex in the wild-type strain CW30, the mutant strain CW30/SM45, and its revertant SM45/CB2. Proteins of crude mitochondrial membrane preparations were separated on a 12% acrylamide gel. The proteins were transferred to nitrocellulose and probed with polyclonal antibodies raised against purified cytochrome bc1 complex. Lane 1, CW30, wild type (COR2 and cyt.b-S223); lane 2, CW30/SM45, original cor2-45 frameshift mutation alone (cor2-45 and cyt.b-S223); lane 3, SM45/CB2, mitochondrial revertant (cor2-45 and cyt.b-P223); lane 4, CCW30, mitochondrial suppressor alone (cyt.b-P223); lane 5, HR2::40k0, cor2 deletion alone (cor2::LEU2 and cyt.b-S223); and lane 6, CHR2::40k0, cor2 deletion with mitochondrial mutation (cor2::LEU2 and cyt.b-P223). Lane 2 contained 30 µg of proteins, the other lanes contained 15 µg of proteins.
[View Larger Version of this Image (27K GIF file)]



RESULTS

The Respiratory Deficient Mutant SM45 Results from a Frameshift in the Nuclear Gene Coding for the Core Protein 2 Subunit of the Cytochrome bc1 Complex

The mutant CW30/SM45 (abbreviated SM45; Table I) exhibits a substrate-conditional phenotype commonly observed in strains with respiratory defective mitochondria. It grows on glucose but cannot grow on non-fermentable carbon sources such as glycerol, ethanol, or lactate, the metabolism of which needs functional mitochondria (Fig. 1). The phenotype of this mutant was complemented by crossing with a rho0 tester strain (KL14-4A/60), indicating that the respiratory defect is caused by a nuclear recessive mutation and not by a deficiency of mitochondrial DNA.


Fig. 1. Growth on non-fermentable medium of the strains described in this work. The strains were grown in glucose and then streaked on ethanol-containing medium. The photographs were taken after 6 (right plate) and 3 (left plate) days of incubation at 28 °C. The names of the strains are: CW30, wild type (COR2 and cyt.b-S223); CW30/SM45, original cor2-45 frameshift mutation alone (cor2-45 and cyt.b-S223); SM45/CB2, mitochondrial revertant (cor2-45 and cyt.b-P223); HR2::40k0, cor2 deletion alone (cor2::LEU2 and cyt.b-S223); CHR2::40k0, cor2 deletion with mitochondrial mutation (cor2::LEU2 and cyt.b-P223); and CCB2, mitochondrial mutation alone (COR2 and cyt.b-P223).
[View Larger Version of this Image (29K GIF file)]


The mutant SM45 is devoid of dithionite-reducible cytochrome b while the amounts of cytochromes a and a3 are not markedly modified, indicating a specific defect at the level of the cytochrome bc1 complex (Fig. 2). A complementing DNA fragment was selected by transformation of the mutant SM45 with a plasmid library of yeast nuclear DNA. The restriction enzyme digestion pattern of the fragment suggested the presence of the COR2 gene (17), and this was confirmed by complementation of a strain carrying a null allele in core protein 2 (strain HR2::40K0). Finally, sequence determination of the chromosomal COR2 locus in SM45 showed the deletion of 1 base pair at codon 165 in comparison with the wild-type COR2 gene. As a result of this mutation, the last 204 residues of wild-type core protein 2 are replaced by 32 novel residues as indicated in Fig. 3. This mutation will be referred to as cor2-45.


Fig. 3. Sequence of the cor2-45 mutation. The nucleotide sequence of the wild-type COR2 gene was determined previously (18) and confirmed in the present work. The cor2-45 mutation consists of a single G deletion that modifies all of the codons after codon 165. As a result, the last 204 residues at the C terminus of the wild-type protein are replaced in the mutant by 32 novel residues.
[View Larger Version of this Image (36K GIF file)]


Assembly of the Cytochrome bc1 Complex Is Blocked at an Early Step by the Nuclear Mutation cor2-45

In order to better understand how the cor2-45 mutation affects assembly of the cytochrome bc1 complex, we used antibodies that recognize core proteins 1 and 2 (29) to test for the presence of these subunits in the mutant. As shown in Fig. 4, these antibodies also recognize a third protein that migrates ahead of core protein 2 and is distinct therefrom. The identity of this protein is not known. It is unlikely to be a subunit of the MPP protease, analogous to the protease subunit in the potato cytochrome bc1 complex (30), since the yeast MPP subunits have apparent molecular masses of 48 and 51 kDa, and the unknown bc1 protein migrates with an apparent molecular mass of less than 40 kDa. The unknown protein is not derived from the COR2 gene since it is not affected by the loss of core 2 protein (Fig. 4, lane 2), and it is present when the COR2 gene is deleted (Fig. 4, lane 5). Although it is possible that this is a spurious impurity, this seems unlikely since a protein of identical size is present in invariant amounts in highly purified preparations of yeast bc1 complex (see Fig. 11 in Ref. 1). Further experimentation is in progress to establish the identity and possible function of this bc1-associated protein.

As expected, no immunological response corresponding to core protein 2 was detected in the mutant carrying the cor2-45 mutation (Fig. 4, lane 2). We did not observe any signal that could correspond to the mutated protein. A possible explanation is that the antibodies react with the C-terminal half of core protein 2, which is lacking in the mutant, or that the mutated protein is more prone to proteolytic degradation.

As shown previously (18) (see also Figs. 1 and 2), a mutant carrying a null allele in the core protein 2 gene grows slowly on non-fermentable substrates and exhibits a low level of cytochrome c reductase activity. Surprisingly, the growth on non-fermentable substrates as well as the cytochrome c reductase activity are virtually abolished by the cor2-45 mutation (Figs. 1 and 2). Moreover, only traces of core protein 1 are present in cells carrying the cor2-45 mutation (Fig. 4, lane 2), whereas core protein 1 is at a nearly normal level in the core 2 deletion strain (Fig. 4, lane 5).

From these results, it is clear that the cor2-45 frameshift mutation has more severe effects than a deletion allele in the COR2 gene. As shown in Fig. 3, the cor2-45 mutation presumably leads to the synthesis of a truncated protein with a net charge of +15 versus +1 for the wild-type protein. This drastic charge and size modification could be responsible for the toxic effects of cor2-45, for instance, by allowing potentially harmful protein-protein interactions between the modified core protein 2 and other subunits of the cytochrome bc1 complex. This led us, as described in the next section, to search for extragenic suppressor mutations, in order to see if the effects of the cor2-45 mutation can be alleviated by a second mutation in another subunit of the complex.

A Mutation of the Mitochondrial DNA Replacing Serine 223 by Proline in Cytochrome b Restores Assembly and Activity of the Cytochrome bc1 Complex in the Nuclear Mutant Deficient for Core Protein 2

Only 1 revertant (SM45/CB2) out of 22 isolates was due to a mutation in mtDNA. The mutation was mapped by rho- deletion mapping to the mitochondrial cytochrome b gene (Table II) and sequenced. The suppressor mutation leads to replacement of the serine codon 223 (TCA) by a proline codon (CCA).

The revertant SM45/CB2 grows on glycerol medium (Fig. 1), exhibits ubiquinol-cytochrome c reductase activity of at least 60% of that of the wild type (Fig. 2, right panel), and spectrally detectable cytochrome b is partially restored (Fig. 2, left panel). In addition, core protein 1, which is dramatically decreased by the cor2-45 mutation, is present at a nearly normal level in the revertant (Fig. 4, lane 3).

We then tested whether the S223P mutation in cytochrome b can also alleviate the effects seen with a null allele in COR2, which encodes core protein 2. To this end, we constructed by cytoduction a yeast strain having the nucleus of the COR2 deletion strain HR2::40K0 and the mtDNA of the revertant SM45/CB2 (Table I). Analysis of this strain (CHR2::40K0) clearly showed that the null allele in COR2 becomes less deleterious in the presence of cytochrome b containing the S223P mutation, as indicated by a markedly faster growth rate on glycerol medium (Fig. 1), a substantially higher content of spectrally detectable cytochrome b (Fig. 2), and a three- to four-fold increase in the ubiquinol-cytochrome c reductase activity (Fig. 2).

As a control, we tested whether the S223P mutation in cytochrome b gives a phenotype when associated with the wild-type core protein 2. To this end, we constructed a strain having the nucleus of the wild-type strain CW30 and the mtDNA of the revertant SM45/CB2 (Table I). This strain (CCW30) exhibits normal cytochrome b content and grows normally on glycerol medium (Fig. 2), indicating that the S223P mutation in cytochrome b by itself has no deleterious effects on the cytochrome bc1 complex.


DISCUSSION

In the studies reported here, we first describe a frameshift mutation (cor2-45) in the nuclear COR2 gene by which the last 204 residues of core protein 2 are replaced by 32 novel residues and show that this mutation severely impairs assembly of the cytochrome bc1 complex. We then show that assembly of an active bc1 complex is restored by a single base pair transition in mitochondrial DNA, which leads to replacement of serine 223 by proline in cytochrome b. This is the first known example of a homoplasmic missense point mutation of the mitochondrial DNA acting as a functional suppressor of a mutation located in a nuclear gene.

Replacement of serine 223 by proline in cytochrome b not only corrects the cytochrome bc1 complex deficiency resulting from the original frameshift mutation, but it also obviates the need for the core 2 protein since it alleviates the respiratory deficiency resulting from its complete deletion. It should be noted that the frameshift mutation strain is more responsive to the suppression by the cytochrome b mutation than is the cor2 deletion strain (60% and 41%, respectively, in terms of activity relative to the wild type are recovered by the S223P replacement). It is possible that the remaining part of core protein 2 in cor2-45 (about half of the wild-type protein) helps the assembly of or stabilize the bc1 complex, which could explain the observed differences in terms of activity and growth rates of the corresponding strains. These unexpected results illustrate unequivocally that the core 2 subunit of the mitochondrial cytochrome bc1 complex is not essential for the electron transfer and energy transducing functions of this respiratory enzyme, which is consistent with the finding that cytochrome bc1 complexes from bacteria do not contain such proteins (3, 4).

Core proteins 1 and 2 are the two largest subunits, contributing about half of the protein mass of the bc1 complex. They are proximal to each other (31), lack any obvious membrane-anchoring domains (17, 18), and extend from the phospholipid bilayer into the matrix phase (32). Cytochrome b is a highly hydrophobic protein with eight alpha -helical segments spanning the inner mitochondrial membrane, as deduced from hydropathy calculations (33, 34), mutant studies (35-37), and phoA fusion experiments (38). In the eight-helix cytochrome b models, serine 223 is located in a matrix-exposed loop that connects transmembrane helices D and E, as shown in Fig. 5. Thus, the suppressor mutation affects a subdomain of cytochrome b that may be in contact with the core proteins.


Fig. 5. The S223 residue of yeast mitochondrial cytochrome b belongs to a matrix-exposed hydrophilic domain. The figure represents the generally accepted eight-helix model of yeast cytochrome b (1, 33-38, 47-49). The black circled amino acids are modified in S. cerevisiae inhibitor-resistance mutants. DIU, diuron; ANA, antimycin; FUN, funiculosin; MYX, myxothiazol; MUC, mucidin; and STI, stigmatellin. As shown in this work, replacement of serine 223 by proline restores the assembly and activity of the cytochrome bc1 complex in a mutant deficient for core protein 2. According to the eight-helix model, the S223 residue belongs to an extra membrane hydrophilic domain facing the matrix phase.
[View Larger Version of this Image (64K GIF file)]


In yeast, a null mutation in core protein 1 does not significantly affect the steady-state concentration of core 2 (39); similarly, a null mutation in core protein 2 does not markedly change that of core protein 1 (Fig. 4) (18, 39). However, a deficiency in either core protein 1 or 2 results in a drastic decrease in immunodetectable cytochrome b content, whereas mutants lacking cytochrome b have normal core protein contents. Since mRNA levels and expression of cytochrome b in pulse-label experiments are not affected by a core protein deficiency, it is thought that the decrease in the steady-state level of cytochrome b results from an increased susceptibility of cytochrome b to proteolytic degradation when the core proteins are absent (39).

We have shown that a modified core protein 2 can elicit the loss of core protein 1. The C-terminal extension created by the frameshift cor2-45 mutation, which contains many basic residues (Fig. 3), could block the proper folding of core 1, thus making this subunit sensitive to proteolytic degradation. If the core proteins bind to cytochrome b, as suggested by the loss of the cytochrome in core protein-deficient yeast strains, the restoration of core protein 1 by the revertant could simply be due to a conformational change in cytochrome b that strengthens its interaction with core protein 1 and thus protects against any deleterious interaction with the mutated core protein 2.

More important, however, is that a single mutation, S223P, in one of its matrix-exposed connecting loops makes the cytochrome b resistant to a core protein 2 deficiency. In N. crassa and plant mitochondria, the core proteins of the cytochrome bc1 complex are proteolytically active (6, 7). In yeast, the core proteins located in the cytochrome bc1 complex appear to be proteolytically inactive homologues of alpha -MPP and beta -MPP (6, 12), which are localized in the matrix (14-16).

From this relationship and the peripheral location of the core proteins at the matrix side of the bc1 complex, we speculate that the proteolytically inactive core proteins bind to the matrix-exposed loop of cytochrome b and thus protect it from proteolysis by a mitochondrial protease. The S223P mutation may render the matrix-exposed loop of the cytochrome intrinsically resistant to mitochondrial protease, thus obviating the requirement for the core proteins. Notably, the cytochromes b in N. crassa and plant mitochondria, in which the core proteins have been shown to be proteolytically active, and likewise those of most eukaryotic mitochondria except yeast, contain a proline at the position equivalent to serine 223 of yeast (35). Furthermore, a single serine to proline mutation proximal to the MPP cleavage site in the presequence of the iron-sulfur protein of the yeast cytochrome bc1 complex blocks proteolysis by MPP.3

Given the complex evolutionary relationships between the core proteins and MPP and the genetic data presented in this study, it will be particularly interesting to see if, in yeast, the core proteins function to protect the cytochrome b against mitochondrial proteases. Further experiments to test this hypothesis are in progress.


FOOTNOTES

*   This work was supported by grants from the European Commission of Communities (Contract SC1-0010-C), the Ligue Nationale Française contre le Cancer, the Ministère de l'Enseignement Supérieur et de la Recherche (to P. P. S), and by National Institutes of Health Grant GM20379 (to B. L. T.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Centre de Génétique Moléculaire, CNRS, Avenue de la Terrasse, 91190 Gif-sur-Yvette, France. Tel.: 33-01 69 82 31 78; Fax: 33-01 69 07 55 39.
§   Was a student in the diplome d'Etudes Approfondies de Génétique Cellulaire et Moléculaire.
1    The abbreviations used are: MPP, matrix processing protease; PCR, polymerase chain reaction.
2    E. Coissac, Gif-sur-Yvette, France, personal communication.
3    J. Nett and B. L. Trumpower, unpublished experiments.

Acknowledgments

We are grateful to E. Petrochillo for stimulating and helpful discussions. The mutant CW30/45 was isolated by S. Robineau who kindly gave it to us for characterization.


REFERENCES

  1. Trumpower, B. L. (1990) Microbiol. Rev. 54, 101-129
  2. Trumpower, B. L. (1990) J. Biol. Chem. 265, 11409-11412 [Free Full Text]
  3. Yang, X., and Trumpower, B. L. (1986) J. Biol. Chem. 261, 12282-12289 [Abstract/Free Full Text]
  4. Wynn, R. M., Gaul, D. F., Choi, W. K., Shaw, R. W., and Knaff, D. B. (1986) Photosynth. Res. 9, 181-195
  5. Yang, X., and Trumpower, B. L. (1988) J. Biol. Chem. 263, 11962-11970 [Abstract/Free Full Text]
  6. Schulte, U., Arretz, M., Schneider, H., Tropschug, M., Wachter, E., Neupert, W., and Weiss, H. (1989) Nature 339, 147-149 [CrossRef][Medline] [Order article via Infotrieve]
  7. Braun, H.-P., Emmermann, M., Kruft, V., and Schmitz, U. K. (1992) EMBO J. 11, 3219-3227 [Abstract]
  8. Emmermann, M., Braun, H.-P., Arretz, M., and Schmitz, U. K. (1993) J. Biol. Chem. 268, 18936-18942 [Abstract/Free Full Text]
  9. Eriksson, A. C., Sjöling, S., and Glaser, E. (1994) Biochim. Biophys. Acta 1186, 221-231
  10. Jänsch, L., Kruft, V., Schmitz, U. K., and Braun, H.-P (1995) Eur. J. Biochem. 228, 878-885 [Abstract]
  11. Glaser, E., Eriksson, A. C., and Sjöling, S. (1994) FEBS Lett. 346, 83-87 [CrossRef][Medline] [Order article via Infotrieve]
  12. Braun, H.-P., and Schmitz, U. K. (1995) Trends Biochem. Sci. 20, 171-174 [CrossRef][Medline] [Order article via Infotrieve]
  13. Kalousek, F., Neupert, W., Omura, T., Schatz, G., and Schmitz, U. K. (1993) Trends Biol. Sci. 18, 249
  14. Jensen, R. E., and Yaffe, M. P. (1988) EMBO J. 7, 3863-3871 [Abstract]
  15. Yang, M., Jensen, R. E., Yaffe, M. P., Opligger, W., and Schatz, G. (1988) EMBO J. 7, 3857-3862 [Abstract]
  16. Witte, C., Jensen, R. E., Yaffe, M. P., and Schatz, G. (1988) EMBO J. 7, 1439-1447 [Abstract]
  17. Tzagoloff, A., Wu, M., and Crivellone, M. (1986) J. Biol. Chem. 261, 17163-17169 [Abstract/Free Full Text]
  18. Oudshoorn, P., Van Steeg, H., Swinkels, B. W., Schoppink, P., and Grivell, L. A. (1987) Eur. J. Biochem. 163, 97-103 [Abstract]
  19. Putrament, A., Baranowska, H., and Pvazmo, W. (1973) Mol. & Gen. Genet. 126, 357-366 [Medline] [Order article via Infotrieve]
  20. di Rago, J.-P., Netter, P., and Slonimski, P. P. (1990) J. Biol. Chem. 265, 15750-15757 [Abstract/Free Full Text]
  21. Bousquet, I., Dujardin, G., Poyton, O., and Slonimski, P. P. (1990) Curr. Genet. 18, 117-124 [Medline] [Order article via Infotrieve]
  22. Dujardin, G., Pajot, P., Groundinsky, O., and Slonimski, P. P. (1980) Mol. & Gen. Genet. 179, 469-482 [Medline] [Order article via Infotrieve]
  23. Hoffman, C. S., and Winston, F. (1987) Gene 57, 267-272 [CrossRef][Medline] [Order article via Infotrieve]
  24. Kruszewska, A., and Slonimski, P. P. (1984) Curr. Genet. 9, 1-10
  25. Slonimski, P. P., and Tzagoloff, A. (1976) Eur. J. Biochem. 73, 276-286
  26. Kotylak, Z., and Slonimski, P. P. (1977) in Mitochondria 1977 -Genetics and Biogenesis of Mitochondria (Bandlow, W., Schweyen, R. J., Wolf, K., and Kaudewitz, F., eds), pp. 161-172, Walter de Gruyter & Co., Berlin
  27. Claisse, M., and Pajot, P. (1974) Eur. J. Biochem. 49, 49-59 [Medline] [Order article via Infotrieve]
  28. di Rago, J.-P., Netter, P., and Slonimski, P. P. (1990) J. Biol. Chem. 265, 3332-3339 [Abstract/Free Full Text]
  29. Graham, L. A., and Trumpower, B. L. (1991) J. Biol. Chem. 266, 22485-22492 [Abstract/Free Full Text]
  30. Emmermann, M., Braun, H. P., and Schmitz (1994) Mol. & Gen. Genet. 245, 237-245 [Medline] [Order article via Infotrieve]
  31. Gonzalez-Halphen, D., Lindorfer, M. A., and Capaldi, R. A. (1988) Biochemistry 27, 7021-7031 [Medline] [Order article via Infotrieve]
  32. Karlsson, B., Hovmöller, S., Weiss, H., and Leonard, K. (1983) J. Mol. Biol. 165, 287-302 [Medline] [Order article via Infotrieve]
  33. Crofts, A. R., Robinson, H., Andrews, K., Van Doren, S., and Berry, E. (1987) in Cytochrome Systems (Papa, S., Chance, B., and Ernster, L., eds), pp. 617-624, Plenum Publishing Corp., New York
  34. Brasseur, R. (1988) J. Biol. Chem. 263, 12571-12575 [Abstract/Free Full Text]
  35. Degli Esposti, M., De Vries, S., Crimi, M., Ghelli, A., Patarnello, T., and Meyer, A. (1993) Biochim. Biophys. Acta 1143, 243-271 [Medline] [Order article via Infotrieve]
  36. di Rago, J.-P., Macadre, C., Lazowska, J., and Slonimski, P. P. (1993) FEBS Lett. 328, 153-158 [CrossRef][Medline] [Order article via Infotrieve]
  37. di Rago, J.-P., Hermann-Le Denmat, S., Pâques, F., Risler, J.-L., Netter, P., and Slonimski, P. P. (1995) J. Mol. Biol. 248, 804-811 [CrossRef][Medline] [Order article via Infotrieve]
  38. Yun, C.-H., Van Doren, S. R., Crofts, A. R., and Gennis, R. B. (1991) J. Biol. Chem. 266, 10967-10973 [Abstract/Free Full Text]
  39. Crivellone, M. D., Wu, M., and Tzagoloff, A. (1988) J. Biol. Chem. 263, 14323-14333 [Abstract/Free Full Text]
  40. Conde, J., and Fink, G. R. (1973) Proc. Natl. Acad. Sci. U. S. A. 73, 3651-3655
  41. Groudinsky, O., Dujardin, G., and Slonimski, P. P. (1981) Mol. & Gen. Genet. 184, 493-503 [Medline] [Order article via Infotrieve]
  42. Coppée, J.-Y., Tokutake, N., Marc, D., di Rago, J.-P., Miyoshi, H., and Colson, A.-M. (1994) FEBS Lett. 339, 1-6 [CrossRef][Medline] [Order article via Infotrieve]
  43. Lemesle-Meunier, D., Brivet-Chevillote, P., di Rago, J.-P., Slonimski, P. P., Bruel, C., Tron, T., and Forget, N. (1993) J. Biol. Chem. 268, 5626-5632
  44. Kruszewska, A., Szczesniak, B., and Claisse, M. (1980) Curr. Genet. 2, 45-51
  45. Netter, P., Robineau, S., and Lemaire, C. (1995) Mol. & Gen. Genet. 246, 445-454 [Medline] [Order article via Infotrieve]
  46. Séraphin, B., Boulet, A., Simon, M., and Faye, G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6810-6814 [Abstract]
  47. di Rago, J.-P, Perea, J., and Colson, A. M. (1990) FEBS Lett. 263, 93-98 [CrossRef][Medline] [Order article via Infotrieve]
  48. Howell, N., and Gilbert, K. (1988) J. Mol. Biol. 203, 607-618 [Medline] [Order article via Infotrieve]
  49. Daldal, F., Tokito, M. K., Davidson, E., and Kaham, M. (1989) EMBO J. 8, 3951-3961 [Abstract]
  50. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  51. Markwell, M. A. K., Haas, S. M., Bieber, L. L., and Tolbert, N. E. (1978) Anal. Biochem. 87, 206-210 [Medline] [Order article via Infotrieve]
  52. Trumpower, B. L., and Edwards, C. A. (1979) J. Biol. Chem. 254, 8697-8706 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.